US Federal Court Upholds Appeal In Favor Of Regeneron, Sanofi On Praluent

(RTTNews) – Regeneron Pharmaceuticals, Inc. (REGN) Thursday announced that the United States Court of Appeals for the Federal Circuit upheld the decision by the U.S. District Court for the District of Delaware that Amgen’s asserted patent claims directed toward PCSK9 antibodies aRead MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario